Leadership changes
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes, November 2026
287
Appointments
163
Departures
21
Browse by role
Get new CFO appointments the day the filing lands.
Browse by month
Filters
3,399 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Cue Biopharma, Inc. | James Ahlers | Chief Financial OfficerCFO | Appointed | Jul 30, 2026 | SEC 8-K |
| Aug 3, 2026 | DANAHER CORP /DE/ | Julie Sawyer Montgomery | President and Chief Executive OfficerCEO | Appointed | Oct 1, 2026 | SEC 8-K |
| Aug 3, 2026 | DANAHER CORP /DE/ | Rainer M. Blair | DirectorDirector | Departed | Oct 1, 2026 | SEC 8-K |
| Aug 3, 2026 | DANAHER CORP /DE/ | Rainer M. Blair | Senior AdvisorSenior Advisor | Appointed | Oct 1, 2026 | SEC 8-K |
| Aug 3, 2026 | EchoStar CORP | Paul Gaske | director and officer positionsdirector and officer positions | Departed | Jul 28, 2026 | SEC 8-K |
| Aug 3, 2026 | Eikon Therapeutics, Inc. | Leon Chen, Ph.D. | DirectorDirector | Departed | Jul 31, 2026 | SEC 8-K |
| Aug 3, 2026 | Eikon Therapeutics, Inc. | Joshua Wolfe | DirectorDirector | Departed | Jul 31, 2026 | SEC 8-K |
| Aug 3, 2026 | Esquire Financial Holdings, Inc. | Michael G. O’Rourke | directordirector | Appointed | n/a | SEC 8-K |
| Aug 3, 2026 | Esquire Financial Holdings, Inc. | Leonard S. Caronia | directordirector | Appointed | n/a | SEC 8-K |
| Aug 3, 2026 | GETTY REALTY CORP /MD/ | Nicole Rapport | Vice President and Chief Accounting OfficerVice President and Chief Accounting Officer | Appointed | Aug 16, 2026 | SEC 8-K |
| Aug 3, 2026 | GETTY REALTY CORP /MD/ | Eugene Shnayderman | Vice President, Chief Accounting Officer and ControllerVice President, Chief Accounting Officer and Controller | Departed | Aug 14, 2026 | SEC 8-K |
| Aug 3, 2026 | Invech Holdings, Inc. | Alexander M. Woods-Leo | President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, and DirectorCEO | Departed | Aug 3, 2026 | SEC 8-K |
| Aug 3, 2026 | Invech Holdings, Inc. | Stephen Ken Adair | President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, and DirectorCEO | Appointed | Aug 3, 2026 | SEC 8-K |
| Aug 3, 2026 | Invesco CurrencyShares Australian Dollar Trust | Jordan Krugman | member of the Board of the Sponsormember of the Board of the Sponsor | Departed | Aug 3, 2026 | SEC 8-K |
| Aug 3, 2026 | Invesco CurrencyShares British Pound Sterling Trust | Jordan Krugman | member of the Board of the Sponsormember of the Board of the Sponsor | Departed | Aug 3, 2026 | SEC 8-K |
| Aug 3, 2026 | Invesco CurrencyShares Canadian Dollar Trust | Matthew Casaccia | member of the Boardmember of the Board | Appointed | Aug 3, 2026 | SEC 8-K |
| Aug 3, 2026 | Invesco CurrencyShares Canadian Dollar Trust | Jordan Krugman | member of the Board of the Sponsormember of the Board of the Sponsor | Departed | Aug 3, 2026 | SEC 8-K |
| Aug 3, 2026 | Invesco CurrencyShares Euro Trust | Jordan Krugman | member of the Board of the Sponsormember of the Board of the Sponsor | Departed | Aug 3, 2026 | SEC 8-K |
| Aug 3, 2026 | Invesco CurrencyShares Japanese Yen Trust | Jordan Krugman | member of the Board of the Sponsormember of the Board of the Sponsor | Departed | Aug 3, 2026 | SEC 8-K |
| Aug 3, 2026 | Invesco CurrencyShares Swiss Franc Trust | Matthew Casaccia | member of the Boardmember of the Board | Appointed | Aug 3, 2026 | SEC 8-K |
- Cue Biopharma, Inc.Appointed
James Ahlers CFO
Filed Aug 3, 2026Effective Jul 30, 2026SEC 8-K
- DANAHER CORP /DE/Appointed
Julie Sawyer Montgomery CEO
Filed Aug 3, 2026Effective Oct 1, 2026SEC 8-K
- DANAHER CORP /DE/Departed
Rainer M. Blair Director
Filed Aug 3, 2026Effective Oct 1, 2026SEC 8-K
- DANAHER CORP /DE/Appointed
Rainer M. Blair Senior Advisor
Filed Aug 3, 2026Effective Oct 1, 2026SEC 8-K
- EchoStar CORPDeparted
Paul Gaske director and officer positions
Filed Aug 3, 2026Effective Jul 28, 2026SEC 8-K
- Eikon Therapeutics, Inc.Departed
Leon Chen, Ph.D. Director
Filed Aug 3, 2026Effective Jul 31, 2026SEC 8-K
- Eikon Therapeutics, Inc.Departed
Joshua Wolfe Director
Filed Aug 3, 2026Effective Jul 31, 2026SEC 8-K
- Esquire Financial Holdings, Inc.Appointed
Michael G. O’Rourke director
Filed Aug 3, 2026SEC 8-K
- Esquire Financial Holdings, Inc.Appointed
Leonard S. Caronia director
Filed Aug 3, 2026SEC 8-K
- GETTY REALTY CORP /MD/Appointed
Nicole Rapport Vice President and Chief Accounting Officer
Filed Aug 3, 2026Effective Aug 16, 2026SEC 8-K
- GETTY REALTY CORP /MD/Departed
Eugene Shnayderman Vice President, Chief Accounting Officer and Controller
Filed Aug 3, 2026Effective Aug 14, 2026SEC 8-K
- Invech Holdings, Inc.Departed
Alexander M. Woods-Leo CEO
Filed Aug 3, 2026Effective Aug 3, 2026SEC 8-K
- Invech Holdings, Inc.Appointed
Stephen Ken Adair CEO
Filed Aug 3, 2026Effective Aug 3, 2026SEC 8-K
Jordan Krugman member of the Board of the Sponsor
Filed Aug 3, 2026Effective Aug 3, 2026SEC 8-K
Jordan Krugman member of the Board of the Sponsor
Filed Aug 3, 2026Effective Aug 3, 2026SEC 8-K
Matthew Casaccia member of the Board
Filed Aug 3, 2026Effective Aug 3, 2026SEC 8-K
Jordan Krugman member of the Board of the Sponsor
Filed Aug 3, 2026Effective Aug 3, 2026SEC 8-K
Jordan Krugman member of the Board of the Sponsor
Filed Aug 3, 2026Effective Aug 3, 2026SEC 8-K
Jordan Krugman member of the Board of the Sponsor
Filed Aug 3, 2026Effective Aug 3, 2026SEC 8-K
Matthew Casaccia member of the Board
Filed Aug 3, 2026Effective Aug 3, 2026SEC 8-K